Laboratory of Bone and Joint Diseases, Center for Integrative Medical Sciences RIKEN, Tokyo, Japan.
Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
J Hum Genet. 2019 Mar;64(3):261-264. doi: 10.1038/s10038-018-0548-2. Epub 2018 Dec 10.
Spondylocostal dysostosis (SCDO) is a heterogeneous group of skeletal disorders characterized by multiple segmentation defects involving vertebrae and ribs. Seven disease genes have been reported as causal genes for SCDO: DLL3, MESP2, TBX6, HES7, RIPPLY2, DMRT2, and LFNG. Here we report a Japanese SCDO case with multiple severe vertebral anomalies from cervical to sacral spine. The patient was a compound heterozygote for c.372delG (p.K124Nfs*) and c.601G>A (p.D201N) variants of LFNG, which encodes a glycosyltransferase (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase). The missense variant was in the DxD motif, an active-site motif of the glycosyltransferase, and its loss of the enzyme function was confirmed by an in vitro enzyme assay. This is the second report of LFNG mutations in SCDO.
脊柱肋骨骺发育不良(SCDO)是一组异质性骨骼疾病,其特征是涉及椎体和肋骨的多个节段性缺陷。已经报道了七个疾病基因是 SCDO 的致病基因: DLL3、MESP2、TBX6、HES7、RIPPLY2、DMRT2 和 LFNG。在这里,我们报告了一例来自颈至骶脊柱的多个严重椎体异常的日本 SCDO 病例。该患者为 LFNG 的 c.372delG(p.K124Nfs*)和 c.601G>A(p.D201N)杂合变体的复合杂合子,LFNG 编码糖基转移酶(O-岩藻糖肽 3-β-N-乙酰氨基葡萄糖基转移酶)。错义变体位于糖基转移酶的活性位点基序 DxD 中,其酶功能缺失通过体外酶测定得到证实。这是 LFNG 突变在 SCDO 中的第二个报告。